Nanoparticle Cures Sepsis in Mice, Potentials for Future Treatment

Researchers from the University of Wisconsin-Madison have engineered a nanoparticle that is able to cure sepsis in mice. Rost9/Shutterstock

The use of engineered nicotinamide adenine dinucleotide [NAD(H)], a molecule common to many animals, resulted in 100 percent sepsis survival in mice, creating a potential future treatment, a University of Wisconsin-Madison study has found.

Researchers from the study say the NAD(H) nanoparticles also have the potential to treat many other diseases because NAD(H) is involved with so many biological pathways.